Drug Shortage Report for APO-MOMETASONE
| Report ID | 196946 |
| Drug Identification Number | 02403587 |
| Brand name | APO-MOMETASONE |
| Common or Proper name | MOMETASONE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MOMETASONE FUROATE |
| Strength(s) | 50MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL NASAL |
| Packaging size | 140 MS |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-25 |
| Estimated end date | 2023-07-14 |
| Actual end date | 2023-07-07 |
| Shortage status | Resolved |
| Updated date | 2024-01-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-01-19 | French | Compare |
| v7 | 2024-01-19 | English | Compare |
| v6 | 2023-07-13 | French | Compare |
| v5 | 2023-07-13 | English | Compare |
| v4 | 2023-07-07 | French | Compare |
| v3 | 2023-07-07 | English | Compare |
| v2 | 2023-06-29 | French | Compare |
| v1 | 2023-06-29 | English | Compare |
Showing 1 to 8 of 8